These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 39247196)
1. Zinc dampens antitumor immunity by promoting Foxp3 Narayan S; Dalal R; Rizvi ZA; Awasthi A Front Immunol; 2024; 15():1389387. PubMed ID: 39247196 [TBL] [Abstract][Full Text] [Related]
2. INFα-2b inhibitory effects on CD4(+)CD25(+)FOXP3(+) regulatory T cells in the tumor microenvironment of C57BL/6 J mice with melanoma xenografts. Yu Y; Huang R; Zong X; He X; Mo W BMC Cancer; 2016 Jul; 16():397. PubMed ID: 27389040 [TBL] [Abstract][Full Text] [Related]
3. Remodeling of the tumor microenvironment via disrupting Blimp1 Dixon ML; Luo L; Ghosh S; Grimes JM; Leavenworth JD; Leavenworth JW Mol Cancer; 2021 Nov; 20(1):150. PubMed ID: 34798898 [TBL] [Abstract][Full Text] [Related]
5. Immunomodulatory Effect of Imiquimod Through CCL22 Produced by Tumor-associated Macrophages in B16F10 Melanomas. Furudate S; Fujimura T; Kambayashi Y; Kakizaki A; Hidaka T; Aiba S Anticancer Res; 2017 Jul; 37(7):3461-3471. PubMed ID: 28668835 [TBL] [Abstract][Full Text] [Related]
6. The Curcumin Analog GO-Y030 Controls the Generation and Stability of Regulatory T Cells. MaruYama T; Kobayashi S; Nakatsukasa H; Moritoki Y; Taguchi D; Sunagawa Y; Morimoto T; Asao A; Jin W; Owada Y; Ishii N; Iwabuchi Y; Yoshimura A; Chen W; Shibata H Front Immunol; 2021; 12():687669. PubMed ID: 34248973 [TBL] [Abstract][Full Text] [Related]
7. Interruption of the intratumor CD8 Geels SN; Moshensky A; Sousa RS; Murat C; Bustos MA; Walker BL; Singh R; Harbour SN; Gutierrez G; Hwang M; Mempel TR; Weaver CT; Nie Q; Hoon DSB; Ganesan AK; Othy S; Marangoni F Cancer Cell; 2024 Jun; 42(6):1051-1066.e7. PubMed ID: 38861924 [TBL] [Abstract][Full Text] [Related]
8. Suppression of Tregs by anti-glucocorticoid induced TNF receptor antibody enhances the antitumor immunity of interferon-α gene therapy for pancreatic cancer. Aida K; Miyakawa R; Suzuki K; Narumi K; Udagawa T; Yamamoto Y; Chikaraishi T; Yoshida T; Aoki K Cancer Sci; 2014 Feb; 105(2):159-67. PubMed ID: 24289533 [TBL] [Abstract][Full Text] [Related]
9. Checkpoint blockade immunotherapy enhances the frequency and effector function of murine tumor-infiltrating T cells but does not alter TCRβ diversity. Kuehm LM; Wolf K; Zahour J; DiPaolo RJ; Teague RM Cancer Immunol Immunother; 2019 Jul; 68(7):1095-1106. PubMed ID: 31104075 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic depletion of CCR8 Van Damme H; Dombrecht B; Kiss M; Roose H; Allen E; Van Overmeire E; Kancheva D; Martens L; Murgaski A; Bardet PMR; Blancke G; Jans M; Bolli E; Martins MS; Elkrim Y; Dooley J; Boon L; Schwarze JK; Tacke F; Movahedi K; Vandamme N; Neyns B; Ocak S; Scheyltjens I; Vereecke L; Nana FA; Merchiers P; Laoui D; Van Ginderachter JA J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33589525 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of the adenosine A2a receptor modulates expression of T cell coinhibitory receptors and improves effector function for enhanced checkpoint blockade and ACT in murine cancer models. Leone RD; Sun IM; Oh MH; Sun IH; Wen J; Englert J; Powell JD Cancer Immunol Immunother; 2018 Aug; 67(8):1271-1284. PubMed ID: 29923026 [TBL] [Abstract][Full Text] [Related]
13. Mst1/Mst2 regulate development and function of regulatory T cells through modulation of Foxo1/Foxo3 stability in autoimmune disease. Du X; Shi H; Li J; Dong Y; Liang J; Ye J; Kong S; Zhang S; Zhong T; Yuan Z; Xu T; Zhuang Y; Zheng B; Geng JG; Tao W J Immunol; 2014 Feb; 192(4):1525-35. PubMed ID: 24453252 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of Nr4a Receptors Enhances Antitumor Immunity by Breaking Treg-Mediated Immune Tolerance. Hibino S; Chikuma S; Kondo T; Ito M; Nakatsukasa H; Omata-Mise S; Yoshimura A Cancer Res; 2018 Jun; 78(11):3027-3040. PubMed ID: 29559474 [TBL] [Abstract][Full Text] [Related]